BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32798398)

  • 21. [Effect of curcumin in combination with bortezomib on proliferation and apoptosis of human multiple myeloma cell line H929 and its mechanism].
    Zhang XY; Bai QX; Huang GS; Zhao H; Chen JJ; Yang LJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):684-8. PubMed ID: 21729550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect and related mechanism of decitabine combined with gemcitabine on proliferation of NK/T cell lymphoma cells.
    Lin L; Liu X; Yu H; Deng H; Peng K; Chen J; Zhang C; Jiang T; Liu X
    Front Pharmacol; 2023; 14():1134895. PubMed ID: 36937854
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combined Effect of Bortezomib and Homoharringtonine on K562 Cells and their Mechanisms].
    Xie C; Tang AP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):395-400. PubMed ID: 29665904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decitabine enhances bortezomib treatment in RPMI 8226 multiple myeloma cells.
    Cao Y; Qiu GQ; Wu HQ; Wang ZL; Lin Y; Wu W; Xie XB; Gu WY
    Mol Med Rep; 2016 Oct; 14(4):3469-75. PubMed ID: 27571872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of PSMB5 on proliferation and bortezomib chemo-resistance in human myeloma cells and its related molecular mechanisms].
    Mo HM; Wu QY; Han DY; Liu R; Ma X; Zhou P; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2017 Dec; 38(12):1053-1057. PubMed ID: 29365400
    [No Abstract]   [Full Text] [Related]  

  • 26. Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulation.
    Cowan AJ; Frayo SL; Press OW; Palanca-Wessels MC; Pagel JM; Green DJ; Gopal AK
    Anticancer Drugs; 2015 Oct; 26(9):974-83. PubMed ID: 26237500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Atractylenolide I Can Induce Apoptosis of U266 Cells and Enhance Bortezomib Effect].
    Mai ZX; Yu TQ; Fan TT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):177-184. PubMed ID: 32027273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol: a proteomic analysis.
    Cecconi D; Zamò A; Parisi A; Bianchi E; Parolini C; Timperio AM; Zolla L; Chilosi M
    J Proteome Res; 2008 Jul; 7(7):2670-80. PubMed ID: 18507431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibition of Autophagy Augments the Anticancer Activity of KPT-330 in Mantle Cell Lymphoma Cells].
    Zhang YL; Chen YH; Zheng RJ; Zheng KJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):470-475. PubMed ID: 38660854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms underlying synergism between circularized tumor necrosis factor-related apoptosis inducing ligand and bortezomib in bortezomib-sensitive or -resistant myeloma cells.
    Leng Y; Hu X; Li L; Nkwocha J; Satta T; Sharma K; Kmeiciak M; Zhou H; Zhang Z; Zhou L; Chen W; Grant S
    Hematol Oncol; 2022 Dec; 40(5):999-1008. PubMed ID: 35789025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific Inhibition of β-Catenin in Jeko-1 Mantle Cell Lymphoma Cell Line Decreases Proliferation and Induces Apoptosis.
    He J; Huang Y; Weng J; Xiao L; Weng K; Ma X
    Med Sci Monit; 2015 Jul; 21():2218-24. PubMed ID: 26227550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro synergistic effect of bortezomib and pirarubicin on proliferation and apoptosis of T cell lymphoma cell line Hut-78 cells].
    Qian ZZ; Wang HQ; Fu K; Ma YL; Hao XS
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):47-51. PubMed ID: 21429402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (-)-Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase-dependent pathway and Bcl-2 family protein modulation.
    Wang J; Xie Y; Feng Y; Zhang L; Huang X; Shen X; Luo X
    Int J Oncol; 2015 Apr; 46(4):1507-15. PubMed ID: 25647297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bortezomib Inhibits Extranodal Natural Killer/T Cell Lymphoma, Nasal Type by Targeting NF-κB Signaling Pathway].
    Li JH; Zhang L; Feng Y; Zou LQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 May; 50(3):311-316. PubMed ID: 31631595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [IL-6 Regulates the Chemosensitivity of Drug-Resistant Multiple Myeloma Cell Lines to Bortezomib through STAT3/Notch Signaling Pathway].
    Liu Y; Sui JZ; Zhu LH; Dai Y; Dong HQ; Cheng P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1474-1481. PubMed ID: 36208252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell Apoptosis.
    Zhang J; Chen B; Wu T; Wang Q; Zhuang L; Zhu C; Fan N; Qing W; Ma Y; Xu X
    PLoS One; 2015; 10(11):e0142422. PubMed ID: 26544558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines.
    Cosenza M; Civallero M; Pozzi S; Marcheselli L; Bari A; Sacchi S
    Hematol Oncol; 2015 Dec; 33(4):166-75. PubMed ID: 25394177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bortezomib could down-regulate the expression of RANKL, inhibit cell proliferation and induce cell apoptosis in the human myeloma cell line RPMI 8226 by activating casepase-3.
    Lin L; Chen D; Xiang ZF; Pei RZ; Zhang PS; Liu XH; Du XH; Lu Y
    Cancer Biomark; 2017 Aug; 20(2):217-224. PubMed ID: 28869453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harnessing Noxa demethylation to overcome Bortezomib resistance in mantle cell lymphoma.
    Leshchenko VV; Kuo PY; Jiang Z; Weniger MA; Overbey J; Dunleavy K; Wilson WH; Wiestner A; Parekh S
    Oncotarget; 2015 Sep; 6(29):27332-42. PubMed ID: 25714012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.
    Sagawa M; Tabayashi T; Kimura Y; Tomikawa T; Nemoto-Anan T; Watanabe R; Tokuhira M; Ri M; Hashimoto Y; Iida S; Kizaki M
    Cancer Sci; 2015 Apr; 106(4):438-46. PubMed ID: 25613668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.